Y. Wang

Cellular and Molecular Neuroscience · Nature Reviews Neuroscience · 2000–2014

A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom Y. Wang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Hardingham

Who trusts Y. Wang overall

  1. R. Malenka
  2. Richard L. Huganir
  3. Michael D. Ehlers
  4. Giulio Tononi
  5. R. Nicoll

Papers from Y. Wang's perspective

Ordered by how strongly the researchers Y. Wang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways (Nature Neuroscience)
  2. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? (Lancet Neurology)
  3. Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions (Science)
  4. Differential Roles of NR2A and NR2B-Containing NMDA Receptors in Cortical Long-Term Potentiation and Long-Term Depression (Journal of Neuroscience)
  5. Role of Distinct NMDA Receptor Subtypes at Central Synapses (Science's STKE)
  6. A key role for TRPM7 channels in anoxic neuronal death. (Cell)
  7. Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions (Stroke)
  8. Synaptic plasticity and memory: an evaluation of the hypothesis.
  9. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. (Cell)
  10. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury (Cellular and Molecular Life Sciences (CMLS))

Their papers